Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
Kyverna Therapeutics touted positive one-year results on Thursday in patients with a rare autoimmune disorder called stiff person syndrome. The condition affects about 6,000 patients in the US, causing painful muscle spasms and stiffness. Kyverna’s ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.